Cynthia Shu

Cynthia Shu

Auto-generated profile, based on publicly available information

Cynthia Shu

Department of Medicine, Endocrinology, David Geffen School of Medicine, University of California, Los Angeles, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2023 in The EMBO Journal
Verified
Journal Article
Open access
RARebeca Acin-Perez
Rebeca Acin-Perez
CBCristiane Benincá
Cristiane Benincá
Lucia Fernandez del RioLucia Fernandez del Rio
Lucia Fernandez del Rio
CSCynthia Shu
Cynthia Shu
SBSiyouneh Baghdasarian
Siyouneh Baghdasarian
OSOrian Shirihai
Orian Shirihai
The maintenance of cellular function relies on the close regulation of adenosine triphosphate (ATP) synthesis and hydrolysis. ATP hydrolysis by mitochondrial ATP Synthase (CV) is induced by loss of proton motive force and inhibited by the mitochondrial protein ATPase inhibitor (ATPIF1). The extent of CV hydrolytic activity and its impact on cellular energetics remains unknown due to the lack of selective hydrolysis inhibitors of CV. We find that CV hydrolytic activity takes place in coupled intact mitochondria and is increased by respiratory chain defects. We identified (+)‐Epicatechin as a selective inhibitor of ATP hydrolysis that binds CV while preventing the binding of ATPIF1. In cells with Complex‐III deficiency, we show that inhibition of CV hydrolytic activity by (+)‐Epichatechin is sufficient to restore ATP content without restoring respiratory function. Inhibition of CV–ATP hydrolysis in a mouse model of Duchenne Muscular Dystrophy is sufficient to improve muscle force without any increase in mitochondrial content. We conclude that the impact of compromised mitochondrial respiration can be lessened using hydrolysis‐selective inhibitors of CV.

1 March 2014 in Nutrition and Dietary Supplements
Verified
Journal Article
Open access
TRTania Reyes-Izquierdo
Tania Reyes-Izquierdo
ZPZbigniew Pietrzkowski
Zbigniew Pietrzkowski
RARuby Argumedo
Ruby Argumedo
CSCynthia Shu
Cynthia Shu
BNBoris Nemzer
Boris Nemzer
SWSlawomir Wybraniec
Slawomir Wybraniec
Aim: We aimed to evaluate the effect of a betalain-rich red beet concentrate (BRC) on joint discomfort and joint function. Methods: Individuals with self-reported knee discomfort were randomized and blinded to treatment with either oral BRC (50 mg twice a day) or placebo. Symptoms of discomfort and joint function were assessed using the Western Ontario and McMaster Universities Arthritis Index (WOMAC) and the McGill Pain Questionnaire (MPQ) before treatment and after 5 and 10 days of treatment. The general level of energy was evaluated using a visual analog scale (VAS) at the same time points. Results: In all, 40 individuals were evaluated in this study, 20 in the BRC group and 20 in the placebo group. The mean participant age was 55 years (range: 45–65). All participants completed the study. Individuals receiving BRC had a 27% better MPQ score after 10 days than did individuals in the placebo group (P=0.003). Furthermore, knee function, as measured by WOMAC score, was 26% better in the BRC group than in the placebo group (P<0.0013). Participants receiving BRC had a significantly better VAS score for energy after 5 (P=0.002) and 10 days (P=0.012) of treatment than did individuals receiving placebo. Conclusion: Short-term use of BRC in individuals with knee discomfort significantly improved knee discomfort and joint function, as measured by WOMAC and MPQ scores, and energy, as measured by a VAS.

14 March 2023 in Life Science Alliance
Verified
Journal Article
Open access
PDF file
Lucia Fernandez del RioLucia Fernandez del Rio
Lucia Fernandez del Rio
CBCristiane Benincá
Cristiane Benincá
FVFrankie Villalobos
Frankie Villalobos
CSCynthia Shu
Cynthia Shu
LSLinsey Stiles
Linsey Stiles
OSOrian Shirihai
Orian Shirihai
Mitochondrial depolarization can initiate reversal activity of ATP synthase, depleting ATP by its hydrolysis. We have recently shown that increased ATP hydrolysis contributes to ATP depletion leading to a maladaptation in mitochondrial disorders, where maximal hydrolytic capacity per CV content is increasing. However, despite its importance, ATP hydrolysis is not a commonly studied parameter because of the limitations of the currently available methods. Methods that measure CV hydrolytic activity indirectly require the isolation of mitochondria and involve the introduction of detergents, preventing their utilization in clinical studies or any high-throughput analyses. Here, we describe a novel approach to assess maximal ATP hydrolytic capacity and maximal respiratory capacity in a single assay in cell lysates, PBMCs, and tissue homogenates that were previously frozen. The methodology described here has the potential to be used in clinical samples to determine adaptive and maladaptive adjustments of CV function in diseases, with the added benefit of being able to use frozen samples in a high-throughput manner and to explore ATP hydrolysis as a drug target for disease treatment.

3 July 2026 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
RARebeca Acin-Perez
Rebeca Acin-Perez
EAEssam A Assali
Essam A Assali
MVMichaela Veliova
Michaela Veliova
JNJennifer Ngo
Jennifer Ngo
ABAlexandra J Brownstein
Alexandra J Brownstein
OSOrian Shirihai
Orian Shirihai
Adrenergic stimulation of brown adipocytes induces a robust detachment of mitochondria from lipid droplets (LD), which is followed by lipolysis and lipid catabolism. However, the signals inducing mitochondria attachment or detachment, and their role in lipid metabolism, remain unknown. Here, we reconstituted mitochondria-LD interaction in brown adipocyte tissue (BAT) ex vivo. We find that removal of mitochondria from lipid droplets permits higher lipolytic activity of recombinant lipases. Testing the effect of thermogenic secondary messengers and metabolites on attachment and detachment identified elevated mitochondrial matrix calcium as a potent inducer of detachment. Further, deletion of the mitochondrial sodium/calcium exchanger, NCLX, resulted in reduced attachment and increased detachment, while activation of NCLX increased attachment. We find that elevated matrix calcium causes detachment by inducing architectural transformation of peridroplet mitochondria (PDM) from their typical LD-surface-bound crescent shape into a round shape. PDE2A inhibition activates NCLX and increases PDM content in BAT in vitro and in vivo. We conclude that a surge in mitochondrial matrix calcium ions serves as a potent signal to induce mitochondrial detachment from lipid droplets, thereby facilitating lipolysis.